Last update 09 Jan 2026

XNW-34017

Overview

Basic Info

Drug Type
Proteolysis-targeting chimeras (PROTAC)
Synonyms
XNW 34, XNW 34017, XNW-34
+ [2]
Target
Aurora A x c-Myc
Action
degraders
Mechanism
Aurora A degraders(Serine/threonine-protein kinase Aurora-A degraders), c-Myc degraders(Myc proto-oncogene protein degraders)
Therapeutic Areas
NeoplasmsDigestive System DisordersRespiratory Diseases+ [1]
Active Indication
Liver CancerMetastatic castration-resistant prostate cancerMetastatic Lung Cancer+ [3]
Inactive Indication-
Originator Organization
Evopoint Biosciences Co., Ltd.Evopoint Biosciences Co., Ltd.
Active Organization
Evopoint Biosciences Co., Ltd.Evopoint Biosciences Co., Ltd.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 1/2
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with XNW-34017
NCT07327294
/ Not yet recruitingPhase 1/2
An Open-label, Multicenter Phase I/II Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Anti-tumor Activity of XNW34017 in Patients With Advanced Solid Tumors
100 Clinical Results associated with XNW-34017
Login to view more data
100 Translational Medicine associated with XNW-34017
Login to view more data
100 Patents (Medical) associated with XNW-34017
Login to view more data
100 Deals associated with XNW-34017
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Liver CancerPhase 2
China
-31 Jan 2026
Metastatic castration-resistant prostate cancerPhase 2
China
-31 Jan 2026
Metastatic Lung CancerPhase 2
China
-31 Jan 2026
Small Cell Lung CancerPhase 2
China
-31 Jan 2026
Advanced Malignant Solid NeoplasmPhase 2
China
Evopoint Biosciences Co., Ltd.Evopoint Biosciences Co., Ltd.
09 Dec 2025
Metastatic Solid TumorIND Approval
China
Evopoint Biosciences Co., Ltd.Evopoint Biosciences Co., Ltd.
07 Nov 2025
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free